Bio-Path Holdings Inc logo

Bio-Path Holdings Inc

$ 1.50 +0.0409 (+2.8%) 10:08 PM EST
P/E:
At Loss
P/B:
0.66
Market Cap:
$ 11.95M
Enterprise V:
$ -1.78M
Volume:
34.97K
Avg Vol (2M):
65.55K
Also Trade In:
Volume:
34.97K
Market Cap $:
11.95M
PE Ratio:
At Loss
Avg Vol (2-Month):
65.55K
Enterprise Value $:
-1.78M
PB Ratio:
0.66
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's lead drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. Its other drugs are BP1002 and BP1003.
Name Current Vs Industry Vs History
Cash-To-Debt 55.49
Equity-to-Asset 0.87
Debt-to-Equity 0.02
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Beneish M-Score -3.84
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 43.59
9-Day RSI 29.06
14-Day RSI 26.55
6-1 Month Momentum % -7.61
12-1 Month Momentum % -23

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.24
Quick Ratio 8.24
Cash Ratio 6.2

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -119.2
Name Current Vs Industry Vs History
ROE % -62.12
ROA % -57.99
ROIC % -592.32
ROC (Joel Greenblatt) % -592.32
ROCE % -61.73

Financials (Next Earnings Date:2023-03-10 Est.)

BPTH's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BPTH

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.97
Beta 0.63
Volatility % 43.77
14-Day RSI 26.55
14-Day ATR ($) 0.178024
20-Day SMA ($) 1.894295
12-1 Month Momentum % -23
52-Week Range ($) 1.28 - 5.28
Shares Outstanding (Mil) 7.96

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bio-Path Holdings Inc Filings

Document Form Filing Date
No Filing Data

Bio-Path Holdings Inc Analysis

Share your research

Headlines

See More
No news.